Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Paxton

Showing results (31-40 of 212) with videos related to

Pageof 22
Sort By:
Ebiomedicine|December 23, 2016
Why Are Some HIV-1 Subtypes More "Wimpy" at Causing Disease?William A Paxton
Medicine, Conflict, and Survival|January 18, 2017
Plague and war: political breakdown and the spread of HIVNathan A Paxton
Current Opinion in HIV and AIDS|October 4, 2012
Considerations regarding antiretroviral chemoprophylaxis and heterosexuals in generalized epidemic settingsLynn A Paxton
Maternal and Child Health Journal|March 23, 2000
Maternal reporting of prepregnancy weight and birth outcome: consistency and completeness compared with the clinical recordS A Lederman, A Paxton
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 7, 2002
Program note. Using UN process indicators to assess needs in emergency obstetric servicesP E Bailey, A Paxton
Retrovirology|October 13, 2009
HIV vaccine: it may take two to tango, but no party time yetBen Berkhout, William A Paxton
Seminars in Immunology|July 7, 1998
Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progressionW A Paxton, S Kang
Current Pharmaceutical Design|December 7, 2010
HIV-1 (co)receptors: implications for vaccine and therapy designGeorgios Pollakis, William A Paxton
Current Opinion in HIV and AIDS|July 31, 2012
Use of (alternative) coreceptors for HIV entryGeorgios Pollakis, William A Paxton
Veterinary Microbiology|December 1, 1989
Detection of antibodies to the agent of tick-borne fever by indirect immunofluorescenceE A Paxton, G R Scott
Pageof 22

Showing results (31-40 of 212) with videos related to

Sort By:
Pageof 22
Ebiomedicine|December 23, 2016
Why Are Some HIV-1 Subtypes More "Wimpy" at Causing Disease?William A Paxton
Medicine, Conflict, and Survival|January 18, 2017
Plague and war: political breakdown and the spread of HIVNathan A Paxton
Current Opinion in HIV and AIDS|October 4, 2012
Considerations regarding antiretroviral chemoprophylaxis and heterosexuals in generalized epidemic settingsLynn A Paxton
Maternal and Child Health Journal|March 23, 2000
Maternal reporting of prepregnancy weight and birth outcome: consistency and completeness compared with the clinical recordS A Lederman, A Paxton
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 7, 2002
Program note. Using UN process indicators to assess needs in emergency obstetric servicesP E Bailey, A Paxton
Retrovirology|October 13, 2009
HIV vaccine: it may take two to tango, but no party time yetBen Berkhout, William A Paxton
Seminars in Immunology|July 7, 1998
Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progressionW A Paxton, S Kang
Current Pharmaceutical Design|December 7, 2010
HIV-1 (co)receptors: implications for vaccine and therapy designGeorgios Pollakis, William A Paxton
Current Opinion in HIV and AIDS|July 31, 2012
Use of (alternative) coreceptors for HIV entryGeorgios Pollakis, William A Paxton
Veterinary Microbiology|December 1, 1989
Detection of antibodies to the agent of tick-borne fever by indirect immunofluorescenceE A Paxton, G R Scott
Pageof 22